|3Jun 25, 7:17 PM ET

Partners Innovation Fund, LLC 3

3 · Akouos, Inc. · Filed Jun 25, 2020

Insider Transaction Report

Form 3
Period: 2020-06-25
Holdings
  • Series B Preferred Stock

    Common Stock (119,997 underlying)
  • Series Seed Preferred Stock

    Common Stock (102,751 underlying)
  • Series A Preferred Stock

    Common Stock (342,505 underlying)
Footnotes (4)
  • [F1]The Series Seed Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
  • [F2]The securities are held by Partners Innovation Fund, LLC ("PIF"). PIF is a limited liability company controlled by its members. The Members of PIF are (1) The General Hospital Corporation (commonly referred to as "MGH"), (2) Brigham and Women's Hospital and (3) Massachusetts Eye and Ear.
  • [F3]The Series A Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
  • [F4]The Series B Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.

Documents

1 file
  • 3
    a3.xmlPrimary

    3